OM1 Secures $85 Million to Improve RWE Tools and Facilitate Personalized Medicine
July 22, 2021
OM1 secured $85 million in funding to support its efforts in bolstering its real world data (RWD) and artificial intelligence tools. OM1 supports chronic disease research using such RWD sources as clinical registries and assists companies seeking regulatory approval.
“OM1 partners with providers, medical societies, payers and manufacturers to harness real-world data for advancing medical research, evaluating health outcomes and personalizing treatment in chronic disease areas, such as dermatology, rheumatology, cardiology, gastroenterology, neurosciences and behavioral health.” Read more here.
(Source: Heather Landi, Fierce Healthcare, 7/20/21)